Since GL26 murine GBM cells also upregulated HN expression in response to cisplatin (Figure S3), we aimed to evaluate whether BV-mediated HN silencing affected the response of these cells to chemotherapy. The gene discussed is MT-RNR2; the disease is glioblastoma.